- Home
- ARHS vs BST Comparison
ARHS vs BST Comparison
Compare ARHS & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$10.69
Company Overview
Basic Information| Metric | ARHS | BST |
|---|---|---|
| Founded | 1986 | 2014 |
| Country | United States | United States |
| Employees | 2630 | N/A |
| Industry | Other Specialty Stores | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARHS | BST |
|---|---|---|
| Price | $10.69 | $41.31 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.56 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 141.1K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $1,361,388,000.00 | N/A |
| Revenue This Year | $8.57 | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | $20.21 | ★ N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $6.61 | $27.87 |
| 52 Week High | $13.02 | $44.50 |
Technical Indicators
Market Signals| Indicator | ARHS | BST |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 54.71 |
| Support Level | $8.68 | $37.51 |
| Resistance Level | $10.55 | $39.80 |
| Average True Range (ATR) | 0.39 | 0.84 |
| MACD | 0.21 | 0.19 |
| Stochastic Oscillator | 99.02 | 84.27 |
Price Performance
Historical Comparison ARHS
BST
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.